Neogenomics

Neogenomics

NEO· Services· Fiscal year ends in December

CEO pay in FY2025Stock -28.6% in FY2025

Tony Zook is the CEO of Neogenomics and was paid $9.1M in FY2025 (Dec).

Pay$100 in the stock at the end of FY22 → $127
CEO pay is from each Neogenomics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives7

See all
  1. 1Tony ZookFY2025
  2. 2Warren StoneFY2025
  3. 3Jeffrey ShermanFY2025
  4. 4Christopher SmithFY2025
  5. 5Melody HarrisFY2025
  6. 6Alicia OlivoFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Neogenomics paid its 7 named executives $32.1M in total in FY2025 (Dec). CEO Tony Zook was paid $9.1M of that.

Name
Tony ZookDirector and Chief Executive Officer
Warren StoneChief Commercial Officer
Jeffrey ShermanChief Financial Officer
Christopher SmithFormer Director and Former Chief Executive Officer
Melody HarrisFormer Chief Operations Officer and Former President, Oncology Data Solutions
Alicia OlivoExecutive Vice President, General Counsel and Business Development

of each named executive, from the Summary Compensation Table of each proxy.

Peers16

See all

The FY2025 (Dec) proxy of Neogenomics names 16 peer companies for pay. Pay versus performance data of Neogenomics for that year is not on file, so it has no rank.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board4

See all
  • Stephen KanovskyDirector · 8 yr on the boardIndependentNominating and Corporate Governance (Chair)—Paid as an executive
  • Michael KellyDirector · 5 yr on the boardIndependentAudit and Finance (Chair), Culture and Compensation—Paid as an executive
  • David PerezDirector · 3 yr on the boardIndependentAudit and Finance, Culture and Compensation (Chair), Innovation, Pipeline and Technology—Paid as an executive
  • Marjorie GreenDirector · 0 yr on the boardIndependentInnovation, Pipeline and Technology—Paid as an executive

The board of the latest proxy (FY2025).

Activity

  1. Pay
    Neogenomics Division head pay rose 59% to $5.1M. The stock fell 29% in FY2025 (Dec).
    DEF 14A
  2. Pay
    Neogenomics Former Chief Operations Officer and Former President, Oncology Data Solutions pay rose 28% to $3.7M. The stock fell 29% in FY2025 (Dec).
    DEF 14A
  3. Pay
    Neogenomics CFO pay rose 34% to $4.7M. The stock fell 29% in FY2025 (Dec).
    DEF 14A
  4. Pay
    Neogenomics Former CEO pay fell 64% to $4.0M. The stock fell 29% in FY2025 (Dec).
    DEF 14A
  5. Pay
    Neogenomics General counsel pay rose 36% to $3.0M. The stock fell 29% in FY2025 (Dec).
    DEF 14A
  6. Board
    Marjorie Green joined the board of Neogenomics. Marjorie Green sits on no other public board.
    3
  7. Pay
    Neogenomics Former Chief Operations Officer and Former President, Oncology Data Solutions pay fell 39% to $2.9M. The stock rose 2% in FY2024 (Dec).
    DEF 14A
  8. Pay
    Neogenomics Division head pay rose 26% to $3.0M. The stock rose 75% in FY2023 (Dec).
    DEF 14A
  9. Pay
    Neogenomics Division head pay fell 33% to $2.4M. The stock rose 75% in FY2023 (Dec).
    DEF 14A
  10. Pay
    Neogenomics Former CEO pay fell 21% to $11.7M. The stock rose 75% in FY2023 (Dec).
    DEF 14A
  11. Board
    Neil Gunn joined the board of Neogenomics. Neil Gunn sits on no other public board.
    3
  12. Board
    Elizabeth Floegel joined the board of Neogenomics. Elizabeth Floegel sits on no other public board.
    3
  13. Board
    Tony Zook joined the board of Neogenomics. Tony Zook now sits on 2 public boards.
    3

Filings6

See all
Proxy statementDEF 14AApr 6, 2026FY2025
Annual report10-KFeb 17, 2026FY2025
Proxy statementDEF 14AApr 8, 2025FY2024
Annual report10-KFeb 18, 2025FY2024
Proxy statementDEF 14AApr 8, 2024FY2023
Annual report10-KFeb 20, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data